ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
ADMA Biologics Announces Commercial Availability of Expanded Vial Size Offerings for BIVIGAM(R) and NABI-HB(R)
August 11, 2021ADMA Biologics Inc. announced the commercial availability of additional vial sizes of BIVIGAM and NABI-HB, which are currently in stock and commercially available to U.S healthcare providers and patients. -
FDA Approves ADMA Biologics Increased IVIG Production
April 29, 2021ADMA Biologics, Inc., a commercial biopharmaceutical company dedicated to specialty plasma-derived biologics, received approval from the U.S. FDA for the company’s expanded manufacturing process, enabling fractionation and purification of a ... -
ADMA Announces It Will Reintroduce Bivigam Into the Market
May 17, 2019ADMA Announces It Will Reintroduce Bivigam Into the Market.
Pharma Sources Insight January 2025
